Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

: Stratifying post-cardiac arrest survivors based on the likelihood of good neurologic outcomes can guide the decision for targeted temperature management (TTM). This study aimed to compare the impact of TTM on neurological improvement among comatose out-of-hospital cardiac arrest (OHCA) survivors stratified by the revised post-cardiac arrest syndrome for therapeutic hypothermia (rCAST) score. : This retrospective observational cohort study was conducted from February 2018 to April 2023 at the emergency department. We calculated the rCAST score immediately after the return of spontaneous circulation in adult patients and compared neurological outcomes at discharge for TTM based on the severity classification of the rCAST score (low: ≤5.5; moderate: 6.0-14.0; high: ≥14.5). We utilized inverse probability of treatment weighting (IPTW) analysis to adjust for selection bias and potential confounding factors between the TTM and non-TTM groups. : Among 300 comatose OHCA survivors, the proportions of patients with good neurological outcomes at discharge were 60.7% (17/28), 38.9% (56/144), and 2.3% (3/128) in the low, moderate, and high-severity rCAST groups, respectively. With increasing severity of the rCAST, the absolute difference in the proportion of patients with good neurological outcomes decreased between those who underwent TTM and those who did not (68.0% vs. 0.0%; = 0.023, 45.2% vs. 27.5%; = 0.037, and 3.5% vs. 0.0%; = 0.221, respectively). After adjusting using IPTW, TTM was associated with good neurologic outcomes in the moderate-severity group (odds ratio, 2.31; 95% confidence interval, 1.09-4.91; = 0.029). : This study suggests that TTM may offer specific benefits for certain groups of OHCA survivors. Further research is needed to refine risk stratification tools for improved patient selection.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12156200PMC
http://dx.doi.org/10.3390/jcm14113931DOI Listing

Publication Analysis

Top Keywords

rcast score
16
ohca survivors
12
neurological outcomes
12
targeted temperature
8
temperature management
8
comatose out-of-hospital
8
out-of-hospital cardiac
8
cardiac arrest
8
arrest survivors
8
post-cardiac arrest
8

Similar Publications

Introduction: Temperature control is a fundamental intervention for neuroprotection following resuscitation from cardiac arrest. However, evidence regarding the efficacy of hypothermia in post-cardiac arrest syndrome (PCAS) remains unclear. Retrospective studies suggest that the clinical effectiveness of hypothermia may depend on the severity of PCAS.

View Article and Find Full Text PDF

: Stratifying post-cardiac arrest survivors based on the likelihood of good neurologic outcomes can guide the decision for targeted temperature management (TTM). This study aimed to compare the impact of TTM on neurological improvement among comatose out-of-hospital cardiac arrest (OHCA) survivors stratified by the revised post-cardiac arrest syndrome for therapeutic hypothermia (rCAST) score. : This retrospective observational cohort study was conducted from February 2018 to April 2023 at the emergency department.

View Article and Find Full Text PDF

Effect Size of Targeted Temperature Management in Pediatric Patients with Post-Cardiac Arrest Syndrome According to the Severity.

Life (Basel)

December 2024

Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 739-0046, Japan.

Aim: Few studies have investigated the differential effects of targeted temperature management (TTM) according to the severity of the condition in pediatric patients with post-cardiac arrest syndrome (PCAS). This study was aimed at evaluating the differential effects of TTM in pediatric patients with PCAS according to a risk classification tool developed by us, the rCAST.

Methods: We used data from a nationwide prospective registry for out-of-hospital cardiac arrest (OHCA) patients in Japan.

View Article and Find Full Text PDF

Using a nationwide multicenter prospective registry in Japan's data, we calculated prognostic and predictive scores, including the Out-of-Hospital Cardiac Arrest (OHCA); Cardiac Arrest Hospital Prognosis (CAHP); Nonshockable rhythm, Unwitnessed arrest, Long no-flow or Long low-flow period, blood PH < 7.2, Lactate > 7.0 mmol/L, End-stage chronic kidney disease on dialysis, Age ≥ 85 years, Still resuscitation, and Extracardiac cause (NULL-PLEASE); revised post-Cardiac Arrest Syndrome for Therapeutic hypothermia (rCAST); and MIRACLE2 scores, for adult patients with cardiac arrest.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the use of urinary catecholamine metabolites, especially vanillactic acid (VLA) and 3-methoxytyramine sulfate (MTS), in enhancing the diagnosis and risk assessment of neuroblastomas compared to traditional markers like homovanillic acid (HVA) and vanillylmandelic acid (VMA).
  • Researchers analyzed urine samples from 68 neuroblastoma patients and 227 controls to establish a scoring system that categorizes participants into risk groups while adjusting for age.
  • The newly developed scoring system showed significantly improved accuracy for diagnosis and risk assessment compared to conventional methods, indicating that VLA and MTS could replace HVA and VMA for
View Article and Find Full Text PDF